HD Research Corp

1. Heron Therapeutics, Inc. $3,234,593 105 payments
2. Pacira Pharmaceuticals Incorporated $2,987,906 16 payments
3. Takeda Pharmaceuticals U.S.A., Inc. $639,249 38 payments
4. RedHill Biopharma Inc. $314,504 29 payments
5. Grifols Biologicals LLC $284,389 12 payments
6. Janssen Research & Development, LLC $194,350 27 payments
7. Hikma Pharmaceuticals USA $176,497 8 payments
8. Eli Lilly and Company $140,043 13 payments
9. SPR Therapeutics, Inc $77,491 2 payments
10. Genentech, Inc. $40,325 7 payments

1. A Phase 1, Pilot, Open Label, Dose Escalation Study to Evaluate the Pharmacokinetics, Pharmacodynamics and Safety, of Exparel Administered As Sciatic Nerve Block in Popliteal Fossa, for Postsurgical Analgesia in Subjects Undergoing Bunionectomy $1,205,666 4 payments
2. A Phase 3, Randomized, Double Blinded, Active Controlled, Multicenter Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of Exparel, Exparel Admixed With Bupivacaine HCL VS. Bupivacaine HCL Administered As Combined Sciatic (In Popliteal Fossa) and Saphenous (In Adductor Canal) Nerve Blocks for Postsurgical Analgesia in Subjects Undergoing Lower Extremity Surgeries (Stride) $888,510 6 payments
3. A Phase 1, Pilot, Open Label, Study to Evaluate the Pharmacokinetics, and Safety, of EXPAREL Administered as Pectoral plane block in Women undergoing Breast Augmentation Surgery $872,877 3 payments
4. Total Knee Arthroplasty (TKA) Study of HTX-011 in an Multimodal Analgesic Regimen (MMA) Regimen $761,328 24 payments
5. Herniorrhaphy Study for Opioid Elimination $642,426 15 payments
6. Total Knee Arthroplasty (TKA) Study of HTX-011 in an Multimodal Analgesic Regimen (MMA) Regimen $612,211 9 payments
7. A Randomized Double-Blind, Double-Dummy, Proof of Concept Phase 2 Study to Evaluate the Efficacy and Safety of Tak-951 Versus Ondansetron in the Prophylaxis of Postoperative Nausea and Vomiting in High-Risk Subjects $612,078 31 payments
8. A Multi-surgery Assessment of ZYNRELEF (HTX-011), AMAZE $591,130 10 payments
9. Opaganib, A Sphingosine Kinase-2 (Sk2) Inhibitor in Covid-19 Pneumonia: A Randomized, Double-Blind, Placebo-Controlled Phase 2A Study, in Adult Subjects Hospitalized With Sars-Cov-2 Positive Pneumonia $314,504 29 payments
10. A Prospective, Randomized, Active-Controlled, Single-blind, Parallel Group Clinical Trial to Evaluate the Safety and Efficacy of Fibrin Sealant Grifols FS Grifols as an Adjunct to Haemostasis During Surgery in Paediatric Subjects $258,152 10 payments

1. Patient care $3,624 2 payments

Only reported on some payments, and a payment can report more than one category, so these amounts overlap.